Association Between ALDH2 Polymorphisms and the Risk of Diabetes Mellitus in Hypertensive Patients

References

• GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–1788. doi:10.1016/S0140-6736(18)32203-7
   PubMed Web of Science ®Google Scholar
• Zhang M, Shi Y, Zhou B, et al. Prevalence, awareness, treatment, and control of hypertension in China, 2004–18: findings from six rounds of a national survey. BMJ. 2023;380:e071952. doi:10.1136/bmj-2022-071952
   PubMedGoogle Scholar
• Wang Z, Chen Z, Zhang L, et al. Status of hypertension in china: results from the china hypertension survey, 2012–2015. Circulation. 2018;137(22):2344–2356. doi:10.1161/CIRCULATIONAHA.117.032380
   PubMed Web of Science ®Google Scholar
• Turana Y, Tengkawan J. Hypertension and stroke in Asia: a comprehensive review from HOPE Asia. J Clin Hypertens. 2021;23(3):513–521. doi:10.1111/jch.14099
   Web of Science ®Google Scholar
• Sanchez R, Musso C. Hypertension and diabetes: an old association to be aware. Curr Hypertens Rev. 2021;17(2):84. doi:10.2174/157340211702211025101445
   PubMed Web of Science ®Google Scholar
• Tatsumi Y, Ohkubo T. Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese. Hypertens Res. 2017;40(9):795–806. doi:10.1038/hr.2017.67
   PubMed Web of Science ®Google Scholar
• Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep. 2012;14(2):160–166. doi:10.1007/s11883-012-0227-2
   PubMed Web of Science ®Google Scholar
• Deng H, Hu P, Li H, et al. Novel lipid indicators and the risk of type 2 diabetes mellitus among Chinese hypertensive patients: findings from the Guangzhou Heart Study. Cardiovasc Diabetol. 2022;21(1):212. doi:10.1186/s12933-022-01660-z
   PubMed Web of Science ®Google Scholar
• Alloubani A, Saleh A, Abdelhafiz I. Hypertension and diabetes mellitus as a predictive risk factors for stroke. Diabetes Metab Syndr. 2018;12(4):577–584. doi:10.1016/j.dsx.2018.03.009
   PubMed Web of Science ®Google Scholar
• Sunkara N, Ha C. Hypertension in diabetes and the risk of cardiovascular disease. Cardiovasc Endocrinol. 2017;6(1):33–38. doi:10.1097/XCE.0000000000000114
   PubMedGoogle Scholar
• Zhang J, Guo Y. The role of aldehyde dehydrogenase 2 in cardiovascular disease. Nat Rev Cardiol. 2023;20(7):495–509. doi:10.1038/s41569-023-00839-5
   PubMed Web of Science ®Google Scholar
• Pang J, Wang J, Zhang Y, Xu F, Chen Y. Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives. Biochim Biophys Acta Mol Basis Dis. 2017;1863(8):1933–1941. doi:10.1016/j.bbadis.2016.10.004
   PubMed Web of Science ®Google Scholar
• Chang YC, Chiu YF, Lee IT, et al. Common ALDH2 genetic variants predict development of hypertension in the SAPPHIRe prospective cohort: gene-environmental interaction with alcohol consumption. BMC Cardiovasc Disord. 2012;12:58. doi:10.1186/1471-2261-12-58
   PubMed Web of Science ®Google Scholar
• Yoshida A, Rzhetsky A, Hsu LC, Chang C. Human aldehyde dehydrogenase gene family. Eur J Biochem. 1998;251(3):549–557. doi:10.1046/j.1432-1327.1998.2510549.x
   PubMedGoogle Scholar
• Mizoi Y, Yamamoto K, Ueno Y, Fukunaga T, Harada S. Involvement of genetic polymorphism of alcohol and aldehyde dehydrogenases in individual variation of alcohol metabolism. Alcohol Alcohol. 1994;29(6):707–710. PMID: 7695788.
   PubMed Web of Science ®Google Scholar
• Perez-Miller S, Younus H, Vanam R, Chen CH, Mochly-Rosen D, Hurley TD. Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nat Struct Mol Biol. 2010;17(2):159–164. doi:10.1038/nsmb.1737
   PubMed Web of Science ®Google Scholar
• Chen YC, Peng GS, Tsao TP, Wang MF, Lu RB, Yin SJ. Pharmacokinetic and pharmacodynamic basis for overcoming acetaldehyde-induced adverse reaction in Asian alcoholics, heterozygous for the variant ALDH2*2 gene allele. Pharmacogenet Genomics. 2009;19(8):588–599. doi:10.1097/FPC.0b013e32832ecf2e
   PubMed Web of Science ®Google Scholar
• Lee SW, Lee PH, Ahn JM, et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion. Circulation. 2019;139(14):1674–1683. doi:10.1161/CIRCULATIONAHA.118.031313
   PubMed Web of Science ®Google Scholar
• Ma C, Yu B, Zhang W, Wang W, Zhang L, Zeng Q. Associations between aldehyde dehydrogenase 2 (ALDH2) rs671 genetic polymorphisms, lifestyles and hypertension risk in Chinese Han people. Sci Rep. 2017;7(1):11136. doi:10.1038/s41598-017-11071-w
   PubMedGoogle Scholar
• He Q, Pan J, Wang L, Fang Y. Prospective study: aldehyde dehydrogenase 2 gene is associated with cardio-cerebrovascular complications in type 2 diabetes patients. J Diabetes Investig. 2021;12(10):1845–1854. doi:10.1111/jdi.13538
   PubMed Web of Science ®Google Scholar
• Wang WZ, Wang CY, Cheng YT, et al. Tracing the origins of Hakka and Chaoshanese by mitochondrial DNA analysis. Am J Phys Anthropol. 2010;141(1):124–130. doi:10.1002/ajpa.21124
   PubMed Web of Science ®Google Scholar
• O’Shea PM, Griffin TP, Fitzgibbon M. Hypertension: the role of biochemistry in the diagnosis and management. Clin Chim Acta. 2017;465:131–143. doi:10.1016/j.cca.2016.12.014
   PubMed Web of Science ®Google Scholar
• Parati G, Lombardi C, Pengo M, Bilo G, Ochoa JE. Current challenges for hypertension management: from better hypertension diagnosis to improved patients’ adherence and blood pressure control. Int J Cardiol. 2021;331:262–269. doi:10.1016/j.ijcard.2021.01.070
   PubMed Web of Science ®Google Scholar
• Harreiter J, Roden M. Diabetes mellitus: definition, classification, diagnosis, screening and prevention (Update 2023). Wien Klin Wochenschr. 2023;135(Suppl 1):7–17. doi:10.1007/s00508-022-02122-y
   PubMed Web of Science ®Google Scholar
• Trinder P, Webster D. Determination of HDL-cholesterol using 2,4,6-tribromo-3-hydroxybenzoic acid with a commercial CHOD-PAP reagent. Ann Clin Biochem. 1984;21(Pt 5):430–433. doi:10.1177/000456328402100516
   PubMed Web of Science ®Google Scholar
• Yu HH, Markowitz R, De Ferranti SD, et al. Direct measurement of LDL-C in children: performance of two surfactant-based methods in a general pediatric population. Clin Biochem. 2000;33(2):89–95. doi:10.1016/s0009-9120(00)00055-2
   PubMed Web of Science ®Google Scholar
• Langlois MR, Descamps OS, van der Laarse A, et al. Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group. Atherosclerosis. 2014;233(1):83–90. doi:10.1016/j.atherosclerosis.2013.12.016
   PubMed Web of Science ®Google Scholar
• Eugui J, Logroño MJ, Ruiz R, Zugaza C, Mirabel JL, Martínez C. Immunoturbidimetry of serum apolipoproteins A-I and B on the Cobas Bio centrifugal analyzer: method validation and reference values. Clin Biochem. 1994;27(4):310–315. doi:10.1016/0009-9120(94)90035-3
   PubMed Web of Science ®Google Scholar
• Oparil S, Acelajado MC, Bakris GL, et al. Hypertension. Nat Rev Dis Primers. 2018;4:18014. doi:10.1038/nrdp.2018.14
   PubMed Web of Science ®Google Scholar
• Li H, Hu YJ, Lin H, Xia H, Guo Y, Wu F. Hypertension and comorbidities in rural and urban Chinese older people: an epidemiological subanalysis from the SAGE study. Am J Hypertens. 2021;34(2):183–189. doi:10.1093/ajh/hpaa146
   PubMed Web of Science ®Google Scholar
• Wang J, Ma JJ, Liu J, Zeng DD, Song C, Cao Z. Prevalence and risk factors of comorbidities among hypertensive patients in China. Int J Med Sci. 2017;14(3):201–212. doi:10.7150/ijms.16974
   PubMed Web of Science ®Google Scholar
• Wu Y, Ni J, Cai X, et al. Positive association between ALDH2 rs671 polymorphism and essential hypertension: a case-control study and meta-analysis. PLoS One. 2017;12(5):e0177023. doi:10.1371/journal.pone.0177023
   PubMed Web of Science ®Google Scholar
• He Z, Guo Q, Ling Y, et al. Aldehyde dehydrogenase 2 rs671 polymorphism and multiple diseases: protocol for a quantitative umbrella review of meta-analyses. Syst Rev. 2022;11(1):185. doi:10.1186/s13643-022-02050-y
   PubMed Web of Science ®Google Scholar
• Hong M, Ling Y, Lu Z, et al. Contribution and interaction of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and triglyceride to diabetes in hypertensive patients: a cross-sectional study. J Diabetes Investig. 2019;10(1):131–138. doi:10.1111/jdi.12856
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhou J, Liu Y, et al. Risk of type 2 diabetes mellitus associated with plasma lipid levels: the rural Chinese cohort study. Diabetes Res Clin Pract. 2018;135:150–157. doi:10.1016/j.diabres.2017.11.011
   PubMed Web of Science ®Google Scholar
• Cui R, Qi Z, Zhou L, Li Z, Li Q, Zhang J. Evaluation of serum lipid profile, body mass index, and waistline in Chinese patients with type 2 diabetes mellitus. Clin Interv Aging. 2016;11:445–452. doi:10.2147/CIA.S104803
   PubMed Web of Science ®Google Scholar
• Ji XW, Feng GS, Li HL, et al. Gender differences of relationship between serum lipid indices and type 2 diabetes mellitus: a cross-sectional survey in Chinese elderly adults. Ann Transl Med. 2021;9(2):115. doi:10.21037/atm-20-2478
   PubMed Web of Science ®Google Scholar
• Zeng D, Huang Q, Yu Z, Wu H. Association between aldehyde dehydrogenase 2 gene rs671 G>A polymorphism and alcoholic liver cirrhosis in southern Chinese Hakka population. J Clin Lab Anal. 2021;35(7):e23855. doi:10.1002/jcla.23855
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu H, Yu Z, et al. ALDH2 Polymorphism rs671 *1/*2 genotype is a risk factor for the development of alcoholic liver cirrhosis in Hakka alcoholics. Int J Gen Med. 2022;15:4067–4077. doi:10.2147/IJGM.S356761
   PubMed Web of Science ®Google Scholar
• Spracklen CN, Horikoshi M, Kim YJ. Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature. 2020;582(7811):240–245. doi:10.1038/s41586-020-2263-3
   PubMed Web of Science ®Google Scholar
• Zhang Y, Deng S, Zhong H, et al. Exploration and clinical verification of the blood co-expression genes of type 2 diabetes mellitus and mild cognitive dysfunction in the elderly. Biomedicines. 2023;11(4):993. doi:10.3390/biomedicines11040993
   PubMed Web of Science ®Google Scholar
• Li GY, Li ZB, Li F, et al. Meta-analysis on the association of ALDH2 polymorphisms and type 2 diabetic mellitus, diabetic retinopathy. Int J Environ Res Public Health. 2017;14(2):165. doi:10.3390/ijerph14020165
   PubMed Web of Science ®Google Scholar
• Xu F, Chen Y, Lv R, et al. ALDH2 genetic polymorphism and the risk of type II diabetes mellitus in CAD patients. Hypertens Res. 2010;33(1):49–55. doi:10.1038/hr.2009.178
   PubMed Web of Science ®Google Scholar
• Kaltenecker D, Themanns M, Mueller KM, et al. Hepatic growth hormone - JAK2 - STAT5 signalling: metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression. Cytokine. 2019;124:154569. doi:10.1016/j.cyto.2018.10.010
   PubMed Web of Science ®Google Scholar
• Wu K, Tan XY, Xu YH, et al. JAK family members: molecular cloning, expression profiles and their roles in leptin influencing lipid metabolism in Synechogobius hasta. Comp Biochem Physiol B Biochem Mol Biol. 2017;203:122–131. doi:10.1016/j.cbpb.2016.10.004
   PubMed Web of Science ®Google Scholar
• Corbit KC, Camporez JPG, Edmunds LR, et al. Adipocyte JAK2 regulates hepatic insulin sensitivity independently of body composition, liver lipid content, and hepatic insulin signaling. Diabetes. 2018;67(2):208–221. doi:10.2337/db17-0524
   PubMed Web of Science ®Google Scholar
• Bousoik E, Montazeri Aliabadi H. “Do We Know Jack” about JAK? A closer look at JAK/STAT signaling pathway. Front Oncol. 2018;8:287. doi:10.3389/fonc.2018.00287
   PubMed Web of Science ®Google Scholar
• Friedrichsen BN, Galsgaard ED, Nielsen JH, Møldrup A. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5). Mol Endocrinol. 2001;15(1):136–148. doi:10.1210/mend.15.1.0576
   PubMedGoogle Scholar
• Jackerott M, Møldrup A, Thams P, et al. STAT5 activity in pancreatic beta-cells influences the severity of diabetes in animal models of type 1 and 2 diabetes. Diabetes. 2006;55(10):2705–2712. doi:10.2337/db06-0244
   PubMed Web of Science ®Google Scholar
• Yao S, Yin X, Chen T, et al. Exploring ALDH2 expression and immune infiltration in HNSC and its correlation of prognosis with gender or alcohol intake. Sci Rep. 2022;12(1):2504. doi:10.1038/s41598-022-06244-1
   PubMed Web of Science ®Google Scholar
• Bisson A, Bodin A, Fauchier G, et al. Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis. Cardiovasc Diabetol. 2021;20(1):24. doi:10.1186/s12933-021-01216-7
   PubMed Web of Science ®Google Scholar
• Bastawrous A, Mathenge W, Wing K, et al. The incidence of diabetes mellitus and diabetic retinopathy in a population-based cohort study of people age 50 years and over in Nakuru, Kenya. BMC Endocr Disord. 2017;17(1):19. doi:10.1186/s12902-017-0170-x
   PubMedGoogle Scholar
• Xue L, Wang H, He Y, et al. Incidence and risk factors of diabetes mellitus in the Chinese population: a dynamic cohort study. BMJ Open. 2022;12(11):e060730. doi:10.1136/bmjopen-2021-060730
   PubMed Web of Science ®Google Scholar
• Koye DN, Magliano DJ, Reid CM, et al. Trends in incidence of ESKD in people with type 1 and type 2 diabetes in Australia, 2002–2013. Am J Kidney Dis. 2019;73(3):300–308. doi:10.1053/j.ajkd.2018.10.005
   PubMed Web of Science ®Google Scholar
• Al-Salameh A, El Bouzegaoui N, Saraval-Gross M. Diabetes and cardiovascular risk according to sex: an overview of epidemiological data from the early Framingham reports to the cardiovascular outcomes trials Annales d’endocrinologie. Ann Endocrinol. 2023;84(1):57–68. doi:10.1016/j.ando.2022.09.023
   PubMed Web of Science ®Google Scholar
• Nakayama Y, Yamaguchi S, Shinzato Y, et al. Retrospective exploratory analyses on gender differences in determinants for incidence and progression of diabetic retinopathy in Japanese patients with type 2 diabetes mellitus. Endocr J. 2021;68(6):655–669. doi:10.1507/endocrj.EJ20-0630
   PubMed Web of Science ®Google Scholar
• Muilwijk M, Bolijn R, Galenkamp H, Stronks K, van Charante EM, van Valkengoed IGM. The association between gender-related characteristics and type 2 diabetes risk in a multi-ethnic population: the HELIUS study. Nutr Metab Cardiovasc Dis. 2022;32(1):142–150. doi:10.1016/j.numecd.2021.09.015
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Chen Z, Rl B, et al. Sex differences in the progression of metabolic risk factors in diabetes development. JAMA Netw Open. 2022;5(7):e2222070. doi:10.1001/jamanetworkopen.2022.22070
   PubMed Web of Science ®Google Scholar
• Maddatu J, Anderson-Baucum E, Evans-Molina C. Smoking and the risk of type 2 diabetes. Transl Res. 2017;184:101–107. doi:10.1016/j.trsl.2017.02.004
   PubMed Web of Science ®Google Scholar
• Holst C, Becker U, Jørgensen ME, Grønbæk M, Tolstrup JS. Alcohol drinking patterns and risk of diabetes: a cohort study of 70,551 men and women from the general Danish population. Diabetologia. 2017;60(10):1941–1950. doi:10.1007/s00125-017-4359-3
   PubMed Web of Science ®Google Scholar